10 Oct 2025
New insights into mechanical circulatory support: Impella in CGS and protected PCI
Sponsored by Johnson & Johnson MedTech
Anchorperson:
M. Lee
Spokesperson:
A. Seth
Summary
This session provides in-depth insights into the evolving role of mechanical circulatory support, focusing on the use of Impella devices in cardiogenic shock (CGS) and protected high-risk percutaneous coronary interventions (PCI). Attendees will gain knowledge on patient selection criteria, the impact of the DanGer trial and new guidelines on clinical decision-making, and optimized treatment protocols for hemodynamic support in routine practice.
Learning Objectives
- To learn best practices around patient identification in mechanical circulatory support supported high-risk PCI
- To learn how the DanGer trial and new guidelines are impacting the decision-making process in treating cardiogenic shock
- To learn how to optimise treatment protocols and better understand hemodynamic support in clinical practice
